Skip to main content
. 2010 May 4;116(7):1045–1050. doi: 10.1182/blood-2009-07-235291

Table 1.

Patient characteristics

Characteristic DS, no. (%) (n = 80) Non-DS, no. (%) (n = 2731) P
Sex .306
    Male 38 (47.5) 1469 (53.8)
    Female 42 (52.5) 1262 (46.2)
Age, y .789
    Less than 10 63 (78.8) 2090 (76.5)
    More than or equal to 10 17 (21.2) 641 (23.5)
WBC .295
    Less than 50 000 70 (87.5) 2253 (82.5)
    More than or equal to 50 000 10 (12.5) 478 (17.5)
Race .001
    White 73 (91.2) 2087 (76.4)
    Black 0 (0) 211 (7.7)
    Other 7 (8.8) 433 (15.9)
NCI risk .194
    Standard 57 (71.2) 1734 (63.5)
    High 23 (28.8) 997 (36.5)
DNA index < .001
    Less than or equal to 1.16 76 (95.0) 2060 (75.4)
    More than 1.16 4 (5.0) 671 (24.6)
Response .169
    CR 76 (95) 2659 (97.4)
    No CR 4 (5) 72 (2.6)
MRD day 8 < .017
    Less than 0.01% 17 (24.6) 713 (29.5)
    0.01%-0.1% 5 (7.3) 420 (17.4)
    0.1%-1.0% 28 (40.6) 619 (25.6)
    More than or equal to 1.0% 19 (27.5) 666 (27.5)
MRD day 29 .713
    Less than 0.01% 48 (73.9) 1885 (78.0)
    0.01%- 0.1% 8 (12.3) 220 (9.1)
    0.1%-1.0% 5 (7.7) 178 (7.4)
    More than or equal to 1.0% 4 (6.1) 132 (5.5)

NCI indicates National Cancer Institute.